Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma.

导出 LinkOut

翻译打印收藏纠错

作者： Chen,Zhang ^[1] ; Jili,Deng ^[1] ; Yan,Xie ^[1] ; Lan,Mi ^[1] ; Weiping,Liu ^[1] ; Xiaopei,Wang ^[1] ; Linjun,Zhao ^[2] ; Yuqin,Song ^[1] ; Jun,Zhu ^[1]

作者单位： Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China. ^[1] Department of Lymphoma, Peking University International Hospital, Beijing, China. ^[2]

关键词 refractory or relapsed classical Hodgkin lymphoma single autologous stem cell transplantation tandem autologous stem cell transplantation unfavorable risk

主题词人类(Humans);造血干细胞移植(Hematopoietic Stem Cell Transplantation);霍奇金病(Hodgkin Disease);肿瘤复发, 局部(Neoplasm Recurrence, Local);回顾性研究(Retrospective Studies);干细胞移植(Stem Cell Transplantation);移植, 自体(Transplantation, Autologous)

DOI 10.1002/cam4.5765

PMID 37081731

发布时间 2023-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer medicine

2023年12卷9期

10351-10362页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除